Search research articles
Contact Us
Filters
Showing results (41-50 of 115) with videos related to
Page
of 12
Sort By:
Journal of Gastrointestinal Oncology
|
May 18, 2023
Medullary carcinoma of the duodenum treated with pembrolizumab: a case report
Louisa Liu, Simmer Kaur, Farshid Dayyani, et al.
Journal of Gastrointestinal Cancer
|
January 26, 2024
Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease
Amy Y Li, Shaina Sedighim, Fatemeh Tajik, et al.
Journal of Gastrointestinal Oncology
|
November 19, 2020
Variability in multimodality treatment influences survival in non-metastatic gastric cancer patients
Tuyen Hoang, Farshid Dayyani, Ariceli Alfaro, et al.
Clinical Colorectal Cancer
|
January 4, 2022
Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol
Mehraneh D Jafari, Joseph C Carmichael, Farshid Dayyani, et al.
Medical Oncology (Northwood, London, England)
|
May 22, 2022
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimen
Farshid Dayyani, Kit Tam, Edward J Kim, et al.
Journal of Thoracic Disease
|
May 13, 2024
Revealing the oncogenic role of elevated GNL3L expression in esophageal squamous cell carcinoma: insights into the STAT3 pathway
Shaobin Yu, Peipei Zhang, Shaojun Xu, et al.
Future Oncology (London, England)
|
March 13, 2023
A multicenter, phase Ib/II, open-label study of tivozanib with durvalumab in advanced hepatocellular carcinoma (DEDUCTIVE)
Sharmeen Mahmood, Daneng Li, Arielle Lee, et al.
Cancers
|
May 28, 2022
<i>BRCA</i>-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms
Naomie Devico Marciano, Gianna Kroening, Farshid Dayyani, et al.
Clinical Colorectal Cancer
|
December 16, 2023
A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic Colorectal Adenocarcinoma
Farshid Dayyani, Jasmine Balangue, Jennifer Valerin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 22, 2002
The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF
Kai-Uwe Belge, Farshid Dayyani, Alexia Horelt, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 115) with videos related to
Sort By:
Page
of 12
Journal of Gastrointestinal Oncology
|
May 18, 2023
Medullary carcinoma of the duodenum treated with pembrolizumab: a case report
Louisa Liu, Simmer Kaur, Farshid Dayyani, et al.
Journal of Gastrointestinal Cancer
|
January 26, 2024
Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease
Amy Y Li, Shaina Sedighim, Fatemeh Tajik, et al.
Journal of Gastrointestinal Oncology
|
November 19, 2020
Variability in multimodality treatment influences survival in non-metastatic gastric cancer patients
Tuyen Hoang, Farshid Dayyani, Ariceli Alfaro, et al.
Clinical Colorectal Cancer
|
January 4, 2022
Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol
Mehraneh D Jafari, Joseph C Carmichael, Farshid Dayyani, et al.
Medical Oncology (Northwood, London, England)
|
May 22, 2022
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimen
Farshid Dayyani, Kit Tam, Edward J Kim, et al.
Journal of Thoracic Disease
|
May 13, 2024
Revealing the oncogenic role of elevated GNL3L expression in esophageal squamous cell carcinoma: insights into the STAT3 pathway
Shaobin Yu, Peipei Zhang, Shaojun Xu, et al.
Future Oncology (London, England)
|
March 13, 2023
A multicenter, phase Ib/II, open-label study of tivozanib with durvalumab in advanced hepatocellular carcinoma (DEDUCTIVE)
Sharmeen Mahmood, Daneng Li, Arielle Lee, et al.
Cancers
|
May 28, 2022
<i>BRCA</i>-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms
Naomie Devico Marciano, Gianna Kroening, Farshid Dayyani, et al.
Clinical Colorectal Cancer
|
December 16, 2023
A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic Colorectal Adenocarcinoma
Farshid Dayyani, Jasmine Balangue, Jennifer Valerin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 22, 2002
The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF
Kai-Uwe Belge, Farshid Dayyani, Alexia Horelt, et al.
Page
of 12